Position in PRGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,299,146
-$2,109,970 QoQ
Shares Held
400,293
-13.1% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 76.69407159255846.ToString("F0")%
Shared 0.ToString("F0")%
None 23.30592840744155.ToString("F0")%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Aristotle Capital Boston, LLC holds $29,799,437 across 3 Drug Manufacturers - Specialty & Generic names. PRGO ranks #3 (14.4% of the industry book) .
All Filings in PRGO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,299,146 | 400,293 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,409,116 | 460,425 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,293,250 | 507,106 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,693,370 | 400,201 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,170,566 | 220,063 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||